Cue Biopharma EV - Enterprise Value 2011-2025 | CUE

Annual EV - Enterprise Value Cue Biopharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
43.5 M	62.4 M	82.4 M	307 M	334 M	309 M	112 M	317 M	1.1 M	376 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
334 M	376 K	157 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Graybug Vision GRAY	472 K	$ 0.44	-11.23 %	$ 9.65 M	USA
AgeX Therapeutics AGE	6.28 M	$ 11.3	-10.17 %	$ 12.2 K	-
Galera Therapeutics GRTX	153 M	$ 0.14	-32.59 %	$ 7.61 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	82.8 M	$ 4.37	-1.58 %	$ 28.1 M	China
Axon Enterprise AXON	41.5 B	$ 598.26	-6.45 %	$ 45.3 B	USA
Caladrius Biosciences CLBS	-6.94 M	$ 0.43	-16.75 %	$ 25.8 M	USA
Sorrento Therapeutics SRNE	1.17 B	$ 0.27	-29.58 %	$ 126 M	USA
BeiGene, Ltd. BGNE	253 B	$ 184.71	0.49 %	$ 251 B	Cayman-islands
ContraFect Corporation CFRX	24.7 M	$ 1.47	-5.16 %	$ 5.39 M	USA
Orchard Therapeutics plc ORTX	724 M	$ 4.93	1.02 %	$ 90.8 M	Britain
Midatech Pharma plc MTP	4.79 M	$ 0.29	-18.52 %	$ 27.3 M	Britain
Advaxis ADXS	-3.02 M	$ 0.31	-9.65 %	$ 45.9 M	USA
Heat Biologics, Inc. HTBX	4.26 B	$ 3.93	-5.76 %	$ 99.8 M	USA
La Jolla Pharmaceutical Company LJPC	231 M	$ 6.2	-	$ 154 M	USA
Zymeworks ZYME	783 M	$ 6.42	-	$ 404 M	Canada
Aeterna Zentaris AEZS	5.52 M	$ 5.72	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	11.4 M	$ 10.5	-	$ 231 M	USA
Kadmon Holdings, Inc. KDMN	27.5 B	$ 9.5	-	$ 1.7 B	USA
BioDelivery Sciences International BDSI	445 M	$ 2.58	-4.8 %	$ 255 M	USA
Zosano Pharma Corporation ZSAN	57 M	$ 0.56	7.23 %	$ 2.72 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	$ 0.5	-	$ 7.46 M	Israel
Kiromic BioPharma KRBP	24.8 M	$ 3.15	6.61 %	$ 3.08 M	USA
Acceleron Pharma Inc. XLRN	-182 M	$ 179.68	-	$ 10.9 B	USA
Albireo Pharma ALBO	417 M	$ 44.15	-0.23 %	$ 916 M	USA
Stealth BioTherapeutics Corp MITO	546 M	$ 0.32	-	$ 23.9 M	USA
Trillium Therapeutics Inc. TRIL	83.6 M	$ 18.44	-	$ 1.94 B	Canada
Kaleido Biosciences KLDO	113 M	$ 0.29	-3.69 %	$ 12.4 M	USA
Entasis Therapeutics Holdings ETTX	51.1 M	$ 2.19	-	$ 105 M	USA
CureVac N.V. CVAC	3.19 B	$ 5.25	-0.38 %	$ 977 M	Germany
Humanigen HGEN	60.3 M	$ 0.04	-81.12 %	$ 4.28 M	USA
Aptinyx APTX	-18.3 M	$ 0.06	-39.0 %	$ 4.57 M	USA
Tyme Technologies TYME	-99 M	$ 0.31	8.07 %	$ 54 M	USA
Evogene Ltd. EVGN	9.72 M	$ 1.16	-1.69 %	$ 27.9 M	Israel
Forward Pharma A/S FWP	513 M	$ 2.64	-0.75 %	$ 18.7 M	Danmark
Applied Genetic Technologies Corporation AGTC	-9.16 M	$ 0.39	-	$ 26.5 M	USA
Celyad Oncology SA CYAD	11.6 M	$ 0.47	-	$ 12.5 M	Belgium
Brickell Biotech BBI	515 K	$ 2.11	-5.38 %	$ 6.06 M	USA
Genocea Biosciences GNCA	64.4 M	$ 0.05	-15.0 %	$ 3.04 M	USA
Codiak BioSciences CDAK	281 M	$ 0.06	-55.98 %	$ 2.15 M	USA
FibroGen FGEN	652 M	$ 11.04	0.33 %	$ 1.07 B	USA
Concert Pharmaceuticals CNCE	14.7 M	$ 8.37	-	$ 401 M	USA
AIkido Pharma AIKI	22.8 M	$ 3.17	1.93 %	$ 17.4 M	USA
Cyclerion Therapeutics CYCN	3.31 M	$ 1.74	-0.63 %	$ 4.38 M	USA
Calithera Biosciences CALA	916 M	$ 0.37	-10.95 %	$ 876 K	USA
Forma Therapeutics Holdings FMTX	452 M	$ 20.01	-	$ 958 M	USA
Arena Pharmaceuticals ARNA	5.65 B	$ 49.55	-6.81 %	$ 3.04 B	USA
Sierra Oncology SRRA	197 M	$ 54.89	-0.05 %	$ 1.34 B	Canada
Regulus Therapeutics RGLS	38.5 M	$ 8.16	-	$ 155 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Yunhong International ZGYH	18.2 B	$ 10.31	0.10 %	$ 92.2 M	China